Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
JOURNAL ARTICLE
Marco Vitolo, Marco Proietti, Vincenzo L Malavasi, Niccolo' Bonini, Giulio Francesco Romiti, Jacopo F Imberti, Laurent Fauchier, Francisco Marin, Michael Nabauer, Tatjana S Potpara, Gheorghe-Andrei Dan, Zbigniew Kalarus, Aldo Pietro Maggioni, Deirdre A Lane, Gregory Y H Lip, Giuseppe Boriani
BACKGROUND: Implementation of the Atrial fibrillation Better Care (ABC) pathway is recommended by guidelines on atrial fibrillation (AF), but the impact of adherence to ABC pathway in patients with cancer is unknown. OBJECTIVES: To investigate the adherence to ABC pathway and its impact on adverse outcomes in AF patients with cancer. METHODS: Patients enrolled in the EORP-AF General Long-Term Registry were analyzed according to (i) No Cancer; and (ii) Prior or active cancer and stratified in relation to adherence to the ABC pathway...
August 23, 2022: European Journal of Internal Medicine
#22
JOURNAL ARTICLE
Michiel Delesie, Arne Ballet, Cedric Hillegeer, Lien Desteghe, Paul Dendale, Hein Heidbuchel
BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are the preferred choice of anticoagulants to prevent stroke in most patients with atrial fibrillation (AF). NOAC's dosing algorithms are defined in the respective Summary of Product Characteristics (SmPC) but the European Heart Rhythm Association (EHRA) Practical Guide can also be used as it considers more complex clinical scenarios. Nevertheless, suboptimal dosing of NOACs compromises the efficacy and safety of this commonly prescribed therapy in the AF population...
August 20, 2022: Clinical Drug Investigation
#23
JOURNAL ARTICLE
Olexandr N Grytsay, Yaroslav V Skybchyk, Dina V Shorikova, Eugene I Shorikov
OBJECTIVE: The aim: To present clinical cases of sudden cardiac death in patients with prolonged and shortened QT interval. PATIENTS AND METHODS: Materials and methods: The study includes description of two different clinical cases with prolonged and shortened QT interval after sudden cardiac death. Verification of the diagnosis was performed using the criteria recommended by the European Society of Cardiology (ESC) and European Heart Rhythm Association (EHRA). RESULTS: Clinical case: Two clinical cases of syncopе with life-threatening arrhythmias, confirmed by electrocardiographic and clinical diagnostic criteria, indicating a change in the dispersion of the QT interval, are presented...
2022: Wiadomości Lekarskie: Organ Polskiego Towarzystwa Lekarskiego
#24
JOURNAL ARTICLE
Julie Boussuge-Roze, Serge Boveda, Saagar Mahida, Ante Anic, Giulio Conte, Julian K R Chun, Eloi Marijon, Frederic Sacher, Pierre Jais
The healthcare sector accounts for nearly 5% of global greenhouse gas emissions (GHG) and is a significant contributor to complex waste. Reducing the environmental impact of technology-heavy medical fields such as cardiac electrophysiology (EP) is a priority. The aim of this survey was to investigate the practice and expectations in European centres on EP catheters environmental sustainability. A 24-item online questionnaire on EP catheters sustainability was disseminated by the EHRA Scientific Initiatives Committee in collaboration with the Lyric Institute...
August 9, 2022: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
#25
JOURNAL ARTICLE
Tze-Fan Chao, Hung-Fat Tse, Wee-Siong Teo, Hyung-Wook Park, Wataru Shimizu, Shih-Ann Chen, Gregory Y H Lip
BACKGROUND: The 4S-AF classification scheme comprises of four domains (stroke risk [St], symptoms [Sy], severity of atrial fibrillation (AF) burden [Sb], and substrate [Su], which has been recommended in the 2020 ESC guidelines to characterize and evaluate patients with AF. OBJECTIVES: We aimed to determine if the 4S-AF scheme would be useful for AF characterization and provides prognostic information in a large contemporary prospective Asian registry conducted by the Asia Pacific Heart Rhythm Society (APHRS)...
June 14, 2022: European Journal of Clinical Investigation
#26
JOURNAL ARTICLE
Yi-Wei Yin, Xiao-Qin Liu, Jia-Qin Gu, Zi-Ran Li, Zheng Jiao
AIMS: Edoxaban is a non-vitamin K antagonist oral anticoagulant (NOAC) widely used for the long-term prevention of stroke in patients with non-valvular atrial fibrillation (NVAF). Adherence to NOAC therapy has been unsatisfactory and decreases over time. Remedial strategies are currently used to address the non-adherence events. Current recommendations, however, are generic and not well supported by evidence. The aim of this study was to explore appropriate remedial dosing regimens for non-adherent edoxaban-treated NVAF patients through Monte Carlo simulation...
March 24, 2022: British Journal of Clinical Pharmacology
#27
JOURNAL ARTICLE
Andreina Carbone, Francesco Santelli, Roberta Bottino, Emilio Attena, Carmine Mazzone, Valentina Parisi, Antonello D'Andrea, Paolo Golino, Gerardo Nigro, Vincenzo Russo
PURPOSE: Older age is associated with inappropriate dose prescription of direct oral anticoagulants. The aim of our study was to describe the prevalence and the clinical predictors of inappropriate DOACs dosage among octogenarians in real-world setting. METHODS: Data for this study were sourced from the multicenter prospectively maintained Atrial Fibrillation (AF) Research Database (NCT03760874). Of the AF patients aged ≥ 80 who received DOACs treatment, 253 patients were selected...
February 9, 2022: European Journal of Clinical Pharmacology
#28
JOURNAL ARTICLE
Guillaume De Ciancio, Marie-Line Erpelding, Laura Filippetti, François Goehringer, Hugues Blangy, Olivier Huttin, Nelly Agrinier, Yves Juillière, Nicolas Sadoul, Christine Selton-Suty
BACKGROUND: Despite guidelines describing the optimal diagnostic and therapeutic procedures for patients with suspected cardiac implantable electronic device (CIED) infections, their management is often challenging. AIMS: To describe our diagnostic and therapeutic practices for suspected CIED infection, and to compare them with European Heart Rhythm Association (EHRA) guidelines. METHODS: Patients hospitalized in the tertiary care Nancy University Hospital for suspected CIED infection from 2014 to 2019 were included retrospectively...
October 2021: Archives of Cardiovascular Diseases
#29
JOURNAL ARTICLE
Mark Segal, Patricia Giuffrida, Lorraine Possanza, David Bucciferro
Integrated behavioral health and primary care is a set of related approaches to enhance care delivery, safety, and quality through closer collaboration and coordination among clinicians and care organizations in these two fields. Technology (e.g., electronic health records (EHR), telehealth, clinical decision support, and standards-based interoperability) can enable integration and improve delivery of care. Reinforcing these opportunities, virtual care and telehealth have dramatically changed care availability and delivery, especially during the COVID-19 pandemic...
October 19, 2021: Journal of Behavioral Health Services & Research
#30
JOURNAL ARTICLE
Marco Proietti, Giulio Francesco Romiti, Marco Vitolo, Tatjana S Potpara, Giuseppe Boriani, Gregory Y H Lip
INTRODUCTION: Bleeding risk assessment is recommended in guidelines for the management of atrial fibrillation (AF). HAS-BLED score was proposed prior to non-vitamin K antagonist oral anticoagulants (NOACs) and has been suggested that the ORBIT score may be superior in predicting bleeds in NOAC users. We aimed to compare the HAS-BLED and ORBIT scores in contemporary AF patients treated with NOACs. METHODS AND RESULTS: We analyzed patients enrolled in the ESC-EHRA EORP-AF General Long-Term Registry...
September 23, 2021: European Heart Journal. Quality of Care & Clinical Outcomes
#31
JOURNAL ARTICLE
Giuseppe Nasso, Roberto Lorusso, Arash Motekallemi, Angelo M Dell'Aquila, Nicola Di Bari, Ignazio Condello, Marco Moscarelli, Saverio Iacopino, Giuseppe F Serraino, Pasquale Mastroroberto, Giuseppe Santarpino, Giuseppe Speziale
BACKGROUND: Much debate is still going on about the best ablation strategy-via endocardial or epicardial approach-in patients with atrial fibrillation (AF), and evidence gaps exist in current guidelines in this area. More specifically, there are no clear long-term outcome data after failed surgical AF ablation. METHODS: Since June 2008, 549 surgical AF ablation procedures through a right minithoracotomy were performed at our institution. From 2008 to 2011, a unipolar radiofrequency device was used (151 patients), whereas from 2011 to 2020 a bipolar radiofrequency device was used (398 patients)...
September 6, 2021: Journal of Cardiothoracic Surgery
#32
JOURNAL ARTICLE
Elijah R Behr, Chiara Scrocco, Arthur A M Wilde, Eloi Marijon, Lia Crotti, Konstantinos E Iliodromitis, Carol A Remme, Jedrzej Kosiuk, Irina Rudaka, Georgia Sarquella Brugada, Katie Frampton, Eric Schulze-Bahr, Kristine Jubele, Carlo de Asmundis, Nynke Hofman, Jacob Tfelt-Hansen, Serge Boveda, Giulio Conte
The aims of this centre-based survey, promoted and disseminated by the European Heart Rhythm Association (EHRA) was to investigate the current practice for the investigation of Sudden Unexplained Death in the Young (SUDY) amongst European countries. An online questionnaire composed of 21 questions was submitted to the EHRA Research Network, European Cardiac Arrhythmia Genetics (ECGen) Focus Group members, and European Reference Network GUARD-Heart healthcare partners. There were 81 respondents from 24 European countries...
August 5, 2021: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
#33
(no author information available yet)
No abstract text is available yet for this article.
June 7, 2021: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
#34
JOURNAL ARTICLE
Roberto F E Pedretti, Marie-Christine Iliou, Carsten W Israel, Ana Abreu, Hielko Miljoen, Ugo Corrà, Christoph Stellbrink, Andreas B Gevaert, Dominic A Theuns, Massimo F Piepoli, Rona Reibis, Jean Paul Schmid, Matthias Wilhelm, Hein Heidbuchel, Heinz Völler, Marco Ambrosetti, Thomas Deneke, Veronique Cornelissen, Frank R Heinzel, Constantinos H Davos, Gulmira Kudaiberdieva, Ines Frederix, Jesper Hastrup Svendsen, Dominique Hansen
Cardiac rehabilitation (CR) is a multidisciplinary intervention including patient assessment and medical actions to promote stabilization, management of cardiovascular risk factors, vocational support, psychosocial management, physical activity counselling, and prescription of exercise training. Millions of people with cardiac implantable electronic devices live in Europe and their numbers are progressively increasing, therefore, large subsets of patients admitted in CR facilities have a cardiac implantable electronic device...
December 29, 2021: European Journal of Preventive Cardiology
#35
JOURNAL ARTICLE
Carina Blomstrom-Lundqvist, Bozena Ostrowska
Cardiac implantable electronic devices (CIED) are potentially life-saving treatments for several cardiac conditions, but are not without risk. Despite dissemination of recommended strategies for prevention of device infections, such as administration of antibiotics before implantation, infection rates continue to rise resulting in escalating health care costs. New trials conveying important steps for better prevention of device infection and an EHRA consensus paper were recently published. This document will review the role of various preventive measures for CIED infection, emphasizing the importance of adhering to published recommendations...
May 25, 2021: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
#36
JOURNAL ARTICLE
Haran Burri, Christoph Starck, Angelo Auricchio, Mauro Biffi, Mafalda Burri, Andre D'Avila, Jean-Claude Deharo, Michael Glikson, Carsten Israel, Chu-Pak Lau, Christophe Leclercq, Charles J Love, Jens Cosedis Nielsen, Kevin Vernooy, Nikolaos Dagres, Serge Boveda, Christian Butter, Eloi Marijon, Frieder Braunschweig, Georges H Mairesse, Marye Gleva, Pascal Defaye, Francesco Zanon, Nestor Lopez-Cabanillas, Jose M Guerra, Vassilios P Vassilikos, Mario Martins Oliveira
With the global increase in device implantations, there is a growing need to train physicians to implant pacemakers and implantable cardioverter-defibrillators. Although there are international recommendations for device indications and programming, there is no consensus to date regarding implantation technique. This document is founded on a systematic literature search and review, and on consensus from an international task force. It aims to fill the gap by setting standards for device implantation.
July 18, 2021: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
#37
JOURNAL ARTICLE
Andrew J S Coats, Stefan D Anker, Andreas Baumbach, Ottavio Alfieri, Ralph Stephan von Bardeleben, Johann Bauersachs, Jeroen J Bax, Serge Boveda, Jelena Čelutkienė, John G Cleland, Nikolaos Dagres, Thomas Deneke, Dimitrios Farmakis, Gerasimos Filippatos, Jörg Hausleiter, Gerhard Hindricks, Ewa A Jankowska, Mitja Lainscak, Christoph Leclercq, Lars H Lund, Theresa McDonagh, Mandeep R Mehra, Marco Metra, Nathan Mewton, Christian Mueller, Wilfried Mullens, Claudio Muneretto, Jean-Francois Obadia, Piotr Ponikowski, Fabien Praz, Volker Rudolph, Frank Ruschitzka, Alec Vahanian, Stephan Windecker, Jose Luis Zamorano, Thor Edvardsen, Hein Heidbuchel, Petar M Seferovic, Bernard Prendergast
Secondary (or functional) mitral regurgitation (SMR) occurs frequently in chronic heart failure (HF) with reduced left ventricular (LV) ejection fraction, resulting from LV remodelling that prevents coaptation of the valve leaflets. Secondary mitral regurgitation contributes to progression of the symptoms and signs of HF and confers worse prognosis. The management of HF patients with SMR is complex and requires timely referral to a multidisciplinary Heart Team. Optimization of pharmacological and device therapy according to guideline recommendations is crucial...
March 31, 2021: European Heart Journal
#38
JOURNAL ARTICLE
Roberto F E Pedretti, Marie-Christine Iliou, Carsten W Israel, Ana Abreu, Hielko Miljoen, Ugo Corrà, Christoph Stellbrink, Andreas B Gevaert, Dominic A Theuns, Massimo F Piepoli, Rona Reibis, Jean Paul Schmid, Matthias Wilhelm, Hein Heidbuchel, Heinz Völler, Marco Ambrosetti, Thomas Deneke, Veronique Cornelissen, Frank R Heinzel, Constantinos H Davos, Gulmira Kudaiberdieva, Ines Frederix, Jesper Hastrup Svendsen, Dominique Hansen
Cardiac rehabilitation (CR) is a multidisciplinary intervention including patient assessment and medical actions to promote stabilization, management of cardiovascular risk factors, vocational support, psychosocial management, physical activity counselling, and prescription of exercise training. Millions of people with cardiac implantable electronic devices live in Europe and their numbers are progressively increasing, therefore, large subsets of patients admitted in CR facilities have a cardiac implantable electronic device...
September 8, 2021: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
#39
JOURNAL ARTICLE
Hein Heidbuchel, Paolo E Adami, Matthias Antz, Frieder Braunschweig, Pietro Delise, Daniel Scherr, Erik E Solberg, Matthias Wilhelm, Antonio Pelliccia
Symptoms attributable to arrhythmias are frequently encountered in clinical practice. Cardiologists and sport physicians are required to identify high-risk individuals harbouring such conditions and provide appropriate advice regarding participation in regular exercise programmes and competitive sport. The three aspects that need to be considered are: (a) the risk of life-threatening arrhythmias by participating in sports; (b) control of symptoms due to arrhythmias that are not life-threatening but may hamper performance and/or reduce the quality of life; and (c) the impact of sports on the natural progression of the underlying arrhythmogenic condition...
June 29, 2020: European Journal of Preventive Cardiology
#40
JOURNAL ARTICLE
Christian Pristipino, Peter Germonpré, Danilo Toni, Horst Sievert, Bernhard Meier, Fabrizio D'Ascenzo, Sergio Berti, Eustaquio Maria Onorato, Francesco Bedogni, Jean-Louis Mas, Paolo Scacciatella, David Hildick-Smith, Fiorenzo Gaita, Paul A Kyrle, John Thomson, Genevieve Derumeaux, Dirk Sibbing, Massimo Chessa, Marius Hornung, Jose Zamorano, Dariusz Dudek, Fabrizio D'Ascenzo, Pierluigi Omedè, Flavia Ballocca, Umberto Barbero, Francesca Giordana, Sebastiano Gili, Mario Iannaccone, Teiji Akagi, Gianpaolo Anzola, John Carroll, Bharat Dalvi, Claudio De Angelis, Ge Junbo, Scott E Kasner, Ina Michel-Behnke, Giuseppe Musumeci, Lars Søndergaard, Giuseppe Tarantini, Giuseppe G L Biondi-Zoccai, Davide Capodanno, Marco Valgimigli, Robert Byrne, Vijay Kunadian
Patent foramen ovale (PFO) is implicated in the pathogenesis of a number of medical conditions but to date only one official position paper related to left circulation thromboembolism has been published. This interdisciplinary paper, prepared with the involvement of eight European scientific societies, reviews the available evidence and proposes a rationale for decision making for other PFO-related clinical conditions. In order to guarantee a strict evidence-based process, we used a modified grading of recommendations, assessment, development, and evaluation (GRADE) methodology...
April 21, 2021: European Heart Journal
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
